Intracavernous Injections of Bone Marrow Mononucleated Cells for Postradical Prostatectomy Erectile Dysfunction: Final Results of the INSTIN Clinical Trial
- 1 December 2017
- journal article
- research article
- Published by Elsevier in European Urology Focus
- Vol. 3 (6) , 643-645
Abstract
No abstract availableKeywords
Funding Information
- Association Française d'Urologie (01089387)
- Institut National de la Santé et de la Recherche Médicale
- Ministère de la Santé
- Direction Générale de l’offre de Soins (06-07)
This publication has 8 references indexed in Scilit:
- Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot StudyEuropean Urology, 2016
- Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical ProstatectomyEuropean Urology, 2015
- Is It Worth Continuing Sexual Rehabilitation after Radical Prostatectomy with Intracavernous Injection of Alprostadil for More than 1 Year?Sexual Medicine, 2015
- Ten-year Outcomes of Sexual Function After Radical Prostatectomy: Results of a Prospective Longitudinal StudyEuropean Urology, 2014
- SOP Conservative (Medical and Mechanical) Treatment of Erectile DysfunctionThe Journal of Sexual Medicine, 2013
- Regenerative Therapy After Cancer: What Are the Risks?Tissue Engineering Part B: Reviews, 2010
- Sample Size Tables for Clinical Studies2008
- Sildenafil Non-Responders: Haemodynamic and Morphometric StudiesEuropean Urology, 2005